Methylphenidate (MPH) and other psychostimulants are highly effective in the treatment of attention deficit hyperactivity disorder (ADHD). Available evidence indicates the therapeutic actions of stimulants in ADHD likely involve the locus coeruleus (LC)-norepinephrine (NE) system. LC neurons display different firing modes (tonic and phasic), each associated with distinct behavioral and cognitive processes. To date, the impact of low, clinically-relevant doses of psychostimulants on LC discharge is unknown. The present study examined the effects of low-dose MPH on LC tonic and phasic discharge in the halothane-anesthetized rat. In these studies, MPH produced a dose-dependent suppression of tonic and phasic discharge that was relatively modest at the lower doses. Nonetheless, these lower doses of MPH suppressed the signal-to-noise ratio of excitatory phasic discharge and increased the signal-to-noise ratio of the inhibitory component of the phasic response. Largely comparable effects were observed with oral and intraperitoneal administration of MPH. Combined, these observations indicate relatively modest suppression of LC neuronal discharge activity by low-dose MPH and that evoked-discharge may be more sensitive than tonic activity to the lowest doses of MPH. It is posited that the behavioral-calming and cognition-enhancing effects of low-dose psychostimulants likely involve modest alterations in LC discharge combined with increased catecholamine efflux within select forebrain regions (i.e. the prefrontal cortex).
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Introduction:
Low doses of methylphenidate (MPH; Ritalin  ) and other psychostimulants are highly effective and widely prescribed for the treatment of attention deficit hyperactivity disorder (ADHD; for review see, Greenhill, 2001) . Importantly, the majority of the documented cognitive-enhancing and behavioral-calming actions of low-dose MPH are not paradoxical or unique to ADHD. Instead, these actions are apparent in both normal human and animal subjects (Arnsten and Dudley, 2005; Berridge, et al., 2006; Kuczenski and Segal, 2002; Mehta, et al., 2001; Rapoport, et al., 1980; Rapoport and Inoff-Germain, 2002) . Moreover, these actions are in contrast to the cognition-impairing and locomotor-activating effects of higher doses of MPH and other stimulants (Segal, 1975; McGaughy and Sarter, 1995) . Neurochemically, higher doses of psychostimulants increase catecholamine efflux widely throughout the brain (Kuczenski and Segal, 1994) . In contrast, low, clinically-relevant doses of MPH preferentially increase catecholamine efflux within the prefrontal cortex, with little effect on these neurotransmitters outside this region (Berridge, et al., 2006; Kuczenski and Segal, 2001; Kuczenski and Segal, 2002) . Combined, these observations indicate that the majority of the behavioral and cognitive effects of low-dose psychostimulants are similar in normal and ADHD subjects and that the actions of low doses of these drugs appear qualitatively distinct from higher doses.
ADHD is associated with a dysregulation of a variety of cognitive and behavioral processes (Solanto, 1998) . Evidence indicates the locus coeruleus (LC)-norepinephrine (NE) system exerts a critical modulatory influence on a number of these processes (for review, Berridge and Waterhouse, 2003; Berridge, 2001; Biederman and Spencer, 1999) . LC neurons display two distinct firing modes: tonic and phasic. Tonic discharge refers to relatively slow and highly-regular state-dependent activity that is associated with the regulation of arousal and a variety of state-dependent processes, including sensory information processing, attention, working memory and motor processes (Aston-Jones and Bloom, 1981b; Foote, et al., 1980; Rajkowski, et al., 1994; Devilbiss and Waterhouse, 2004; Arnsten and Dudley, 2005) . Phasic discharge is driven by novel or salient sensory stimuli and is characterized by a brief burst of 2-3 action potentials followed by a sustained period of suppression of discharge activity (200-500 ms), associated with alerting/orienting reactions, sustained attention, and/or decision making and action (Clayton, et al., 2004; Rajkowski, et al., 1994) . JPET #110015 5 Given the above information, dysfunction of the LC-NE system maybe a contributing factor in ADHD (Biederman and Spencer, 1999) . Additionally or alternatively, alterations in LC discharge activity patterns may well contribute to the therapeutic actions of low-dose stimulants in the treatment of this disorder. Previous studies indicate that moderate-to-high doses of psychostimulants profoundly suppress tonic LC discharge activity via activation of α 2 -autoreceptors (Graham and Aghajanian, 1971; Ryan, et al., 1985) . However, our recent neurochemical studies indicate that clinically-relevant doses of MPH exert minimal effects on NE (and dopamine) efflux outside the prefrontal cortex (Berridge, et al., 2006) . To date, the actions of low-dose stimulants on tonic and phasic LC discharge activity are not known. The current studies examined the effects of intraperitoneal (IP) and oral administration of low doses of MPH on tonic and sensory-driven phasic LC discharge, as measured by single-unit extracellular recordings in halothane-anesthetized rats. The range of doses used in the current study were previously demonstrated to produce plasma concentrations in the rat that are associated with clinical efficacy in humans and to improve working memory and sustained attention in this species similar to that observed in humans (Berridge, et al., 2006; Kuczenski and Segal, 2002) .
Results obtained in the current study demonstrate that when administered in this dose range, MPH produced only a modest suppression of both tonic LC discharge and the excitatory component of the phasic response while increasing the magnitude of the inhibitory component of the phasic response. At higher doses, a larger magnitude suppression of both tonic and phasic excitatory discharge was observed accompanied by an increase in the duration of the inhibitory component of the LC phasic response. These actions suggest that low, clinically-relevant doses of MPH modestly dampen spontaneous and evoked LC discharge. It is hypothesized that, combined, relatively robust increases in NE (and dopamine) efflux within select forebrain regions (i.e. prefrontal cortex) and modest suppression of LC discharge activity likely contribute to the unique behavioral and cognitive actions of low-dose psychostimulants. A preliminary report of these findings has been published previously in abstract form (Devilbiss and Berridge, 2003 were used in all studies. Animals were housed in pairs and provided with free access to food and water for approximately one week following arrival. Animals were anesthetized with halothane (Halocarbon Laboratories, River Edge, NJ; 1-4% in air) and placed in a stereotaxic instrument.
The stereotaxic incisor bar was set at 11.5 mm below zero. Body temperature was maintained at 36-38°C throughout the experiment.
The skull was exposed and a surface-to-depth bipolar electrode was implanted into the frontal cortex (A+3.2, L±1.2, V-2.0) to record electroencephalographic activity (EEG), as previously described (Berridge and Foote, 1991) . The EEG electrode was secured to a skull screw with a cyanoacrylate adhesive (Loctite 382, Rocky Hill, CT). EEG signals were amplified and filtered (0.3-100.0 Hz) and recorded digitally with a 1401 A/D computer interface and Spike2 Software (CED instrument, UK). Halothane concentrations were adjusted to maintain stable large-amplitude, slow-wave EEG activity while permitting a 2-second tail-pinch to elicit robust EEG desynchronization that persisted for 10-120 seconds beyond the pinch ( Figure 1A ).
A second hole was made in the skull above the LC (A -12.6, L ±1.2). A glass micropipette (impedance 5-12 Megohm) was lowered into the LC (V -6.0 to -6.5) to record electrophysiological activity of single LC neurons. Methods used for LC recordings were similar to those utilized previously (Adams and Foote, 1988; Berridge and Foote, 1991) . Briefly, amplification and discrimination of LC neuronal discharge activity was made using an amplifier/window discriminator (Fintronics, New Haven, CT) and recorded simultaneously with EEG activity using a 1401 A/D computer interface and Spike2 Software. LC neurons were tentatively identified using previously described criteria (Foote, et al., 1980 ; Figure 1B ).
Sensory-evoked phasic discharge of LC neurons was elicited with 1.3 mA biphasic 50 ms pulses delivered to the hind-paw contralateral to the LC recording electrode at a frequency of 0.1 Hz.
For hind-paw stimulation, a 30g hypodermic needle was inserted into the skin above the joints between the tarsal, metatarsal, and phalanges of the first digit of the hind-paw (Valentino and Foote, 1987) . Under these conditions, LC phasic discharge does not habituate to repeated footshock (Valentino and Foote, 1987) . saline. Clinically, psychostimulants are administered orally and exert therapeutic actions at low doses that result in peak plasma concentrations within the range of 8-40 ng/ml (Swanson and Volkow, 2002) . Although MPH is administered orally for the treatment of ADHD, the vast majority of studies that have examined the behavioral, neurochemical, and electrophysiological actions of moderate and high-dose stimulants in rodents utilized IP or subcutaneous administration. Therefore, in the current study it was of interest to examine the effects of both IP and oral MPH on LC discharge activity. In the rat, MPH has been estimated to yield clinicallyrelevant peak plasma concentrations when administered IP at a dose of 0.25-0.5 mg/kg and orally at a dose of 1.0-3.0 mg/kg (Berridge, et al., 2006; Kuczenski and Segal, 2002) . Importantly, these low doses of MPH enhance working memory and sustained attention in rats, similar to that observed in humans (Arnsten and Dudley, 2005; Berridge, et al., 2006) . Moreover, when administered in the rat at these low doses, MPH is devoid of arousal-increasing and locomotoractivating effects and, under conditions associated with elevated locomotion, suppresses locomotor activity (Berridge, et al., 2006; Kuczenski and Segal, 2002) . Thus, within this dose range, MPH produces a number of behavioral/cognitive actions that are similar to that observed in both normal and ADHD human subjects (Solanto, 1998) . Based on these observations, the current study examined the effects of 0.25 mg/kg, 0.5 mg/kg and 1.0 mg/kg MPH administered JPET #110015 8 IP and 2.0 mg/kg and 4.0 mg/kg MPH administered by oral gavage. MPH was administered orally via a length of PE50 tubing inserted into the stomach prior to placing the animal into the stereotaxic instrument.
The half-life of MPH in the rat is approximately 1 hour (Wargin, et al., 1983) with peak plasma levels observed approximately at 5-15 minutes following oral or IP administration, respectively (Berridge, et al., 2006) . Consistent with this, low-doses of MPH induced increases in DA and NE reach a maximum within 15-30 minute following drug administration and return to baseline over the subsequent 30-60 minute (depending on dose). Thus, based on these observations, LC activity was determined for 60 min post-MPH administration.
Data Analysis: Spike trains from recorded LC neurons were used to construct rate histograms of spontaneous activity and peri-stimulus time histograms (PSTH) of foot-shock-evoked phasic discharge. Excitatory and inhibitory components of the phasic response were calculated using procedures similar to those previously described (Aston-Jones and Bloom, 1981a) . In brief, tonic LC firing rates were calculated as the mean discharge rate during the 5 minute periods between periods of foot-shock stimulation. Additionally, the incidence of burst activity within periods of tonic discharge was calculated. Burst discharge was defined as two or more action potentials occurring at a rate faster than 10 Hz with a interspike interval of less than 125 milliseconds (Page and Abercrombie, 1999 ). An additional measure of spontaneous discharge rate was calculated during the 10 minute period (n = 60) of stimulus presentation. In these analyses, average LC discharge was calculated during the 2.5 seconds immediately prior to footshock. This second metric of spontaneous firing rate was used to: 1) control for possible changes in tonic firing rates during trains of foot-shock and; 2) provide a baseline discharge rate for phasic response signal-to-noise calculations (see below).
The excitatory component of the phasic response was calculated as the mean frequency of discharge during the epoch where the response exceeded 3 SD above spontaneous rates (indicated between a-b; Figure 1C ). The magnitude of the inhibitory component was calculated as the firing rate within the period between 100-500 ms following stimulus presentation (e-f; Figure 1C ) subtracted from the average spontaneous firing rate. The duration of the inhibitory component was calculated as the time that the mean frequency of discharge was 1 SD below JPET #110015 9 spontaneous firing rates (Aston-Jones and Bloom, 1981a SD background ] were used for these studies over the more simple measure of signal-to-noise (excitatory response -background) due to the additional sensitivity of this measure to potential changes in the variability of the underlying tonic firing rate that could result from periodic footshock. For these analyses, tonic discharge was calculated from the 2.5 seconds immediately preceding foot-shock rather than from the 5-minute block of tonic discharge preceding footshock trials. This was done to avoid potential changes in the underlying tonic firing rate that could result from periodic foot-shock. Despite concerns that foot-shock might alter tonic discharge rates, in the end no substantial differences were observed between measures of tonic LC activity and background discharge rates during foot-shock. Data collected in the current study were expressed as a percentage of baseline discharge rates (pre-vehicle or pre-MPH) or percentage change from saline, which permits comparisons between cells with different tonic or phasic discharge rates. A mixed two-way ANOVA with both repeated (time) -and between (treatment) -measures was used to determine statistical significance of MPH-induced changes in LC discharge as a function of dose and time. Post-hoc comparisons were performed using the Fisher LSD test.
Histology. Following each experiment, Chicago blue dye was iontophoretically ejected into the recording site (glass electrodes contain 3M NaCl + 2% Chicago blue). The animal was deeply anesthetized and perfused with 50 ml of 4% formaldehyde. The brain was placed in 50 ml of the perfusion solution for a minimum of 24 hr. Frozen 40-µm coronal sections were collected through the LC and counterstained with Neutral Red.
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Results:
Overview: Extracellular activity of individual LC neurons was recorded from 88 animals (one cell/animal), before and after IP or oral gavage vehicle or MPH administration. LC activity is sensitive to alterations in anesthetic plane as indicated by EEG activity patterns in the halothane-anesthetized rat (Berridge, et al., 1993; Berridge and Abercrombie, 1999) . Therefore, to avoid alterations in LC activity that might result from drug-induced changes in arousal, EEG was monitored throughout the experimental session (see Methods and Figure 1 ). Data from LC recordings were eliminated from further analysis if EEG desynchronization was observed.
Single cell recordings were obtained largely from the central third of the LC nucleus, as confirmed by histological analysis ( Figure 1D ). Tonic firing rate and phasic responses to sensory stimuli were similar to those previously reported for LC neurons (Akaike, 1982) . Under Effects of MPH on phasic activity of LC neurons.
Additional analyses examined the effects of MPH on the excitatory and inhibitory components of phasic discharge. Analysis of phasic activation examined: 1) stimulus-evoked phasic discharge (evoked-discharge), and 2) excitatory discharge normalized to spontaneous firing rates (signal-to-noise). Analyses of the inhibitory component examined: 1) suppression of spontaneous discharge, 2) percent suppression relative to baseline discharge rates, and 3) the duration of this component. In contrast, 1.0 mg/kg IP produced a more pronounced suppression of evoked-discharge (-58 %).
Despite the robust suppressive effects of 1.0 mg/kg on evoked discharge, only the lowest dose of IP MPH produced a significant suppression of the signal-to-noise of evoked-discharge ( Figure   5C ; dose, F (3,40) = 5.71, p = 0.022; time, F (3,120) = 2.44, p = 0.068; dose X time F (9,120) = 1.85, p = 0.066), indicating a larger effect on evoked discharge than tonic discharge at this dose.
Similar to that observed with IP administration, all doses of oral MPH significantly suppressed evoked-discharge ( Figure 5B Oral administration of low-dose MPH tended to increase phasic inhibition, although these effects did not reach statistical significance (dose, F (2,27) = 2.42, p = 0.108; time, F (3,81) = 5.16, p = 0.003; dose X time F (6,81) = 1.91, p = 0.09). Similar to that observed with IP administration, the lowest oral dose produced a moderate suppression of LC discharge (-63 %) during the inhibitory component whereas, the highest dose had a larger impact on phasic inhibition. Also similar to that observed with IP administration, the signal-to-noise ratio of the inhibitory response was significantly facilitated at the lowest but not the highest dose of MPH ( Figure 6D 
Discussion:
At low doses, MPH and other psychostimulants exert largely similar behavioral-calming and cognition-enhancing actions in normal individuals and ADHD patients (Solanto, 1998) .
These actions are in contrast to those of higher doses of stimulants which impair cognitive function and exert pronounced reinforcing, locomotor-activating and/or stereotypy-inducing actions (Segal, 1975; McGaughy and Sarter, 1995) . Moreover, in contrast, to that observed with moderate-to-high doses of MPH and other psychostimulants (Kuczenski and Segal, 1994) low,
clinically-relevant doses of MPH increase NE and DA efflux primarily within the prefrontal cortex, having minimal effects on NE/DA efflux outside this region (Berridge, et al., 2006) .
Substantial evidence suggests LC discharge mode and rate are critical variables for a variety of behavioral/cognitive processes (for review, Berridge and Waterhouse, 2003) .
Moreover, it is well-documented that higher doses of psychostimulants profoundly suppress tonic LC discharge activity, likely contributing to the cognition-impairing actions of high-dose psychostimulants (Graham and Aghajanian, 1971; Ishimatsu, et al., 2002; Lacroix and Ferron, 1988; Ryan, et al., 1985) . The absence of information regarding the actions of low, clinicallyrelevant doses of psychostimulants on LC signaling limits our ability to formulate hypotheses regarding the role of the LC in the therapeutic actions of these drugs. The current studies characterized the actions of low-dose MPH on tonic and phasic LC discharge. These studies demonstrate that when administered at low, clinically-relevant doses (see below), MPH produces a relatively modest dose-dependent suppression of both tonic and phasic LC discharge. At the lowest doses, MPH also suppressed the signal-to-noise ratio of evoked phasic discharge.
Moreover, the lower doses of MPH increased phasic inhibition and the signal-to-noise ratio of phasic inhibition. Given that moderate alterations in LC discharge are associated with changes in forebrain signal processing and cognition (Arnsten and Li, 2005; Devilbiss and Waterhouse, 2004; Rajkowski, et al., 1994) , relatively modest effects of low-dose MPH on LC discharge activity could nonetheless have a significant impact on cognition and behavior.
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Dose and Route of Administration:
The behavioral and cognitive actions of psychostimulants are highly dependent on dose. Low-dose psychostimulants produce behavioral-calming and cognitive-enhancing actions that are in distinct contrast to the behavioral actions of higher doses of these drugs. Importantly, these behavioral and cognitive actions are not limited to ADHD, but are also observed in normal human and animal subjects (Mehta, et al., 2001; Rapoport, et al., 1980; Kuczenski and Segal, 2002; Solanto, 1998; Wilens, et al., 2004; Arnsten and Dudley, 2005; Rapoport and Inoff-Germain, 2002) . Combined, these and other observations indicate that the majority of the documented behavioral actions of low-dose stimulants are not unique to ADHD. Moreover, these observations indicate that when administered at low doses in both humans and rats, MPH and other psychostimulants are, in fact, not stimulatory but instead exert behavioral-calming and cognition-enhancing actions.
Clinically, MPH is routinely administered by an oral route. Nonetheless, the vast majority of information on the neural actions of psychostimulants has involved the use of IP or subcutaneous injection. Thus, to better compare with the existing literature, the current studies utilized both oral and IP MPH administration at doses that have been estimated to produce peak plasma levels in rats that fall within the range associated with clinical efficacy (Berridge, et al., 2006; Kuczenski and Segal, 2002) . Importantly, at these doses, MPH improves working memory and sustained attention while suppressing elevated baseline levels of locomotor activity in rats and mice (Arnsten and Dudley, 2005; Berridge, et al., 2006; Kuczenski and Segal, 2002 ).
In the current studies, we observed similar actions of oral and IP MPH on LC neuronal activity, when dose is adjusted to produce similar plasma levels. This is consistent with previous microdialysis studies demonstrating a largely similar time course and magnitude of action of oral and IP MPH on NE and dopamine efflux when dose is adjusted appropriately (Berridge, et al., 2006; Kuczenski and Segal, 2001; Kuczenski and Segal, 2002) .
Behavioral relevance of MPH-induced alterations in LC discharge. The neural
substrates underlying the behavioral and cognitive actions of low-dose stimulants are currently unknown. However, available evidence suggests an involvement of the LC-NE system in these actions (for review, Arnsten and Li, 2005; Biederman and Spencer, 1999) . Moreover, substantial evidence indicates that optimal performance on a variety of cognitive tasks depends on a relatively narrow range of tonic and phasic LC discharge (Clayton, et al., 2004; Rajkowski, et al., JPET #110015 15 1994). For example, performance in a vigilance task is associated with an intermediate level of
tonic LC discharge which in turn promotes maximal phasic evoked discharge (Aston-Jones and Bloom, 1981b; Rajkowski, et al., 1994) . On this task, both high and low LC tonic discharge are associated with attentional impairment (Rajkowski, et al., 1994; Clayton, et al., 2004) . This inverted-U dose-response curve is similar to that observed for the relationship between NE neurotransmission and working memory (Arnsten, 2001) .
The current results demonstrate that in contrast to that observed with higher doses (Lacroix and Ferron, 1988; Ishimatsu, et al., 2002) , low doses of MPH documented to improve cognitive performance in rats (Berridge, et al., 2006) produce only a moderate suppression of tonic LC discharge activity. This moderate suppression might help to maintain phasic activity within a range that is associated with sustained and focused attention (Clayton, et al., 2004) .
Importantly, a majority of phasic discharge was preserved following low doses of MPH. Thus, at these doses MPH preserves the transfer of temporally-locked sensory information to LC terminal fields. This likely contrasts with that of higher doses associated with cognitive impairment. At the lower doses tested, MPH produced a significant, though relatively modest, suppression of the signal-to-noise ratio of phasic discharge. It is possible that this action facilitates suppression of attending to and/or responding to distracting, non-salient, environmental stimuli.
The current studies demonstrate that low-dose MPH enhances the magnitude and signalto-noise ratio of LC phasic inhibition. Few studies have addressed the role of the phasic inhibitory component of LC discharge in cognitive function. However, previous studies demonstrate that cortical responses are enhanced when coincident with the LC phasic inhibitory component (Waterhouse, et al., 1998) . Thus, MPH-induced facilitation of phasic inhibition may facilitate signal processing within cortical regions associated with attention and impulsivity (e.g. prefrontal cortex). Therefore, actions of MPH on phasic inhibition could well be an important component of the unique behavioral actions of low doses of this drug.
Methodological considerations. These data were obtained from lightly halothaneanesthetized rats, as determined by EEG recordings. This preparation provides certain advantages over the unanesthetized animal, including the facilitation of obtaining stable and high-quality single-unit recordings over prolonged periods while avoiding state-dependent JPET #110015
16 alterations in LC discharge. Importantly, tonic discharge rates of LC neurons under these anesthetic conditions (1.5 Hz) are similar to those observed in awake animals (Aston-Jones and Bloom, 1981b; Foote, et al., 1980) . Moreover, the use of this preparation permits direct comparison with results obtained in previous studies that examined the effects of higher doses of psychostimulants on tonic LC neuronal activity. In both anesthetized and unanesthetized animals, tonic and phasic LC firing are dependent on cortical activity state (Berridge and Foote, 1991; Berridge, et al., 1993; Berridge and Abercrombie, 1999) . Given that stimulants can activate forebrain EEG (Berridge and Morris, 2000) , cortical EEG activity was monitored in all animals. Under these experimental conditions, these doses of MPH did not produce obvious cortical activation, consistent with minimal wake-promoting actions observed with these doses in unanesthetized animals (Berridge et al., 2006) . Thus, MPH-induced alterations in LC discharge
are not due to indirect actions of MPH on forebrain neuronal activity state. Anesthesia can reduce tonic and phasic LC activity, particularly at deeper levels of anesthesia (Aston-Jones and Bloom, 1981a ). In the current study, a relatively low level of anesthesia was administered, as indicated by a robust tail-pinch-induced EEG activation. Under these conditions, we observed robust sensory-evoked phasic responses and tonic discharge rates, similar to that observed in unanesthetized animals (Aston-Jones and Bloom, 1981b) . Combined, these observations indicate it is likely that the actions of MPH observed in the current studies reflect actions that occur in the absence of anesthesia, although, future studies will need to verify this.
Summary:
The current observations indicate that when administered at doses that yield clinically-relevant plasma levels, MPH produces a moderate suppression of both tonic and evoked phasic discharge. The signal-to-noise ratio of the evoked phasic discharge was suppressed following the lowest dose of MPH. In contrast, phasic inhibition and the signal-tonoise ratio of this component were increased by low-dose MPH. Evidence suggests that combined, these actions may well contribute to the ability of low-dose stimulants to suppress A) IP administration of MPH significantly increased the duration of the inhibitory component only at the highest dose. B) Oral MPH increased the duration of the inhibitory component only at the 4.0 mg/kg dose. *P < 0.05, **P < 0.01, relative to vehicle-treated animals.
